APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artesunate Medicines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artesunate Medicines Market Analysis and Forecast 2026-2032

Report ID 17396736022 January 2026194 pages

Choose your research edition.

Industry ResearchArtesunate Medicines Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Artesunate Medicines Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Artesunate Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artesunate Medicines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Artesunate Medicines Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Artesunate Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artesunate Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artesunate Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artesunate Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artesunate Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artesunate Medicines include Shin Poong, Sanofi Aventis, MCW Healthcare, Ipca Laboratories, Fosun Pharma (Guilin), Cipla, Ajanta Pharma and Acino, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artesunate Medicines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artesunate Medicines, also provides the revenue of main regions and countries. Of the upcoming market potential for Artesunate Medicines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artesunate Medicines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artesunate Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artesunate Medicines revenue, projected growth trends, production technology, application and end-user industry.

Artesunate Medicines Segment by Company

Shin Poong

Sanofi Aventis

MCW Healthcare

Ipca Laboratories

Fosun Pharma (Guilin)

Cipla

Ajanta Pharma

Acino

Artesunate Medicines Segment by Type

Monoaromatic Artesunate

Compound Artesunate

Artesunate Medicines Segment by Application

Hospital

Clinic

Other

Artesunate Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artesunate Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artesunate Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artesunate Medicines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artesunate Medicines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artesunate Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monoaromatic Artesunate Major Player Table 3. Compound Artesunate Major Player Table 4. Global Artesunate Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Other Major Player Table 8. Artesunate Medicines Industry Trends Table 9. Artesunate Medicines Industry Drivers Table 10. Artesunate Medicines Industry Opportunities and Challenges Table 11. Artesunate Medicines Industry Restraints Table 12. Global Artesunate Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Artesunate Medicines Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Artesunate Medicines Market Share by Region (2021-2026) Table 15. Global Artesunate Medicines Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Artesunate Medicines Market Share by Region (2027-2032) Table 17. Global Artesunate Medicines Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Artesunate Medicines Revenue Market Share by Players (2021-2026) Table 19. Global Artesunate Medicines Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Artesunate Medicines Key Players Headquarters & Area Served Table 21. Global Artesunate Medicines Players, Product Type & Application Table 22. Global Artesunate Medicines Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Artesunate Medicines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Artesunate Medicines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artesunate Medicines Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Artesunate Medicines Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Artesunate Medicines Revenue Market Share by Type (2021-2026) Table 29. Global Artesunate Medicines Revenue Market Share by Type (2027-2032) Table 30. Global Artesunate Medicines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Artesunate Medicines Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Artesunate Medicines Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Artesunate Medicines Revenue Market Share by Application (2021-2026) Table 34. Global Artesunate Medicines Revenue Market Share by Application (2027-2032) Table 35. Shin Poong Company Information Table 36. Shin Poong Business Overview Table 37. Shin Poong Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Shin Poong Artesunate Medicines Product Portfolio Table 39. Shin Poong Recent Development Table 40. Sanofi Aventis Company Information Table 41. Sanofi Aventis Business Overview Table 42. Sanofi Aventis Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sanofi Aventis Artesunate Medicines Product Portfolio Table 44. Sanofi Aventis Recent Development Table 45. MCW Healthcare Company Information Table 46. MCW Healthcare Business Overview Table 47. MCW Healthcare Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. MCW Healthcare Artesunate Medicines Product Portfolio Table 49. MCW Healthcare Recent Development Table 50. Ipca Laboratories Company Information Table 51. Ipca Laboratories Business Overview Table 52. Ipca Laboratories Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Ipca Laboratories Artesunate Medicines Product Portfolio Table 54. Ipca Laboratories Recent Development Table 55. Fosun Pharma (Guilin) Company Information Table 56. Fosun Pharma (Guilin) Business Overview Table 57. Fosun Pharma (Guilin) Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio Table 59. Fosun Pharma (Guilin) Recent Development Table 60. Cipla Company Information Table 61. Cipla Business Overview Table 62. Cipla Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Cipla Artesunate Medicines Product Portfolio Table 64. Cipla Recent Development Table 65. Ajanta Pharma Company Information Table 66. Ajanta Pharma Business Overview Table 67. Ajanta Pharma Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Ajanta Pharma Artesunate Medicines Product Portfolio Table 69. Ajanta Pharma Recent Development Table 70. Acino Company Information Table 71. Acino Business Overview Table 72. Acino Artesunate Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Acino Artesunate Medicines Product Portfolio Table 74. Acino Recent Development Table 75. North America Artesunate Medicines Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Artesunate Medicines Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Artesunate Medicines Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Artesunate Medicines Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Artesunate Medicines Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Artesunate Medicines Revenue by Country (US$ Million) & (2027-2032) Table 82. Europe Artesunate Medicines Revenue by Type (2021-2026) & (US$ Million) Table 83. Europe Artesunate Medicines Revenue by Type (2027-2032) & (US$ Million) Table 84. Europe Artesunate Medicines Revenue by Application (2021-2026) & (US$ Million) Table 85. Europe Artesunate Medicines Revenue by Application (2027-2032) & (US$ Million) Table 86. Europe Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Artesunate Medicines Revenue by Country (2021-2026) & (US$ Million) Table 88. Europe Artesunate Medicines Revenue by Country (US$ Million) & (2027-2032) Table 89. China Artesunate Medicines Revenue by Type (2021-2026) & (US$ Million) Table 90. China Artesunate Medicines Revenue by Type (2027-2032) & (US$ Million) Table 91. China Artesunate Medicines Revenue by Application (2021-2026) & (US$ Million) Table 92. China Artesunate Medicines Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Artesunate Medicines Revenue by Type (2021-2026) & (US$ Million) Table 94. Asia Artesunate Medicines Revenue by Type (2027-2032) & (US$ Million) Table 95. Asia Artesunate Medicines Revenue by Application (2021-2026) & (US$ Million) Table 96. Asia Artesunate Medicines Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Artesunate Medicines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Artesunate Medicines Revenue by Region (US$ Million) & (2021-2026) Table 99. Asia Artesunate Medicines Revenue by Region (US$ Million) & (2027-2032) Table 100. SAMEA Artesunate Medicines Revenue by Type (2021-2026) & (US$ Million) Table 101. SAMEA Artesunate Medicines Revenue by Type (2027-2032) & (US$ Million) Table 102. SAMEA Artesunate Medicines Revenue by Application (2021-2026) & (US$ Million) Table 103. SAMEA Artesunate Medicines Revenue by Application (2027-2032) & (US$ Million) Table 104. SAMEA Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. SAMEA Artesunate Medicines Revenue by Country (2021-2026) & (US$ Million) Table 106. SAMEA Artesunate Medicines Revenue by Country (US$ Million) & (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Artesunate Medicines Image Figure 2. Global Artesunate Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artesunate Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monoaromatic Artesunate Image Figure 5. Compound Artesunate Image Figure 6. Global Artesunate Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Artesunate Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Artesunate Medicines Market Size (US$ Million) & (2021-2032) Figure 12. Global Artesunate Medicines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Artesunate Medicines Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Artesunate Medicines Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Artesunate Medicines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Artesunate Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Artesunate Medicines Revenue Market Share by Type (2021-2032) Figure 19. Global Artesunate Medicines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Artesunate Medicines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Artesunate Medicines Revenue Market Share by Application (2021-2032) Figure 22. North America Artesunate Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Artesunate Medicines Revenue Share by Type (2021-2032) Figure 24. North America Artesunate Medicines Revenue Share by Application (2021-2032) Figure 25. North America Artesunate Medicines Revenue Share by Country (2021-2032) Figure 26. United States Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Artesunate Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Artesunate Medicines Revenue Share by Type (2021-2032) Figure 31. Europe Artesunate Medicines Revenue Share by Application (2021-2032) Figure 32. Europe Artesunate Medicines Revenue Share by Country (2021-2032) Figure 33. Germany Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Artesunate Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Artesunate Medicines Revenue Share by Type (2021-2032) Figure 43. China Artesunate Medicines Revenue Share by Application (2021-2032) Figure 44. Asia Artesunate Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Artesunate Medicines Revenue Share by Type (2021-2032) Figure 46. Asia Artesunate Medicines Revenue Share by Application (2021-2032) Figure 47. Asia Artesunate Medicines Revenue Share by Region (2021-2032) Figure 48. Japan Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Artesunate Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Artesunate Medicines Revenue Share by Type (2021-2032) Figure 56. SAMEA Artesunate Medicines Revenue Share by Application (2021-2032) Figure 57. SAMEA Artesunate Medicines Revenue Share by Country (2021-2032) Figure 58. Brazil Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Artesunate Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Monoaromatic Artesunate
  • Compound Artesunate
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Shin Poong
  • Sanofi Aventis
  • MCW Healthcare
  • Ipca Laboratories
  • Fosun Pharma (Guilin)
  • Cipla
  • Ajanta Pharma
  • Acino

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artesunate Medicines Market by Type
  3. 1.2.1 Global Artesunate Medicines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monoaromatic Artesunate
  5. 1.2.3 Compound Artesunate
  6. 1.3 Artesunate Medicines Market by Application
  7. 1.3.1 Global Artesunate Medicines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Artesunate Medicines Market Dynamics
  1. 2.1 Artesunate Medicines Industry Trends
  2. 2.2 Artesunate Medicines Industry Drivers
  3. 2.3 Artesunate Medicines Industry Opportunities and Challenges
  4. 2.4 Artesunate Medicines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artesunate Medicines Market Perspective (2021-2032)
  2. 3.2 Global Artesunate Medicines Growth Trends by Region
  3. 3.2.1 Global Artesunate Medicines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artesunate Medicines Market Size by Region (2021-2026)
  5. 3.2.3 Global Artesunate Medicines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artesunate Medicines Revenue by Players
  2. 4.1.1 Global Artesunate Medicines Revenue by Players (2021-2026)
  3. 4.1.2 Global Artesunate Medicines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artesunate Medicines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artesunate Medicines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artesunate Medicines Key Players Headquarters & Area Served
  7. 4.4 Global Artesunate Medicines Players, Product Type & Application
  8. 4.5 Global Artesunate Medicines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artesunate Medicines Market CR5 and HHI
  11. 4.6.3 2025 Artesunate Medicines Tier 1, Tier 2, and Tier 3
5 Artesunate Medicines Market Size by Type
  1. 5.1 Global Artesunate Medicines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artesunate Medicines Revenue by Type (2021-2032)
  3. 5.3 Global Artesunate Medicines Revenue Market Share by Type (2021-2032)
6 Artesunate Medicines Market Size by Application
  1. 6.1 Global Artesunate Medicines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artesunate Medicines Revenue by Application (2021-2032)
  3. 6.3 Global Artesunate Medicines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Shin Poong
  2. 7.1.1 Shin Poong Company Information
  3. 7.1.2 Shin Poong Business Overview
  4. 7.1.3 Shin Poong Artesunate Medicines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Shin Poong Artesunate Medicines Product Portfolio
  6. 7.1.5 Shin Poong Recent Developments
  7. 7.2 Sanofi Aventis
  8. 7.2.1 Sanofi Aventis Company Information
  9. 7.2.2 Sanofi Aventis Business Overview
  10. 7.2.3 Sanofi Aventis Artesunate Medicines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Aventis Artesunate Medicines Product Portfolio
  12. 7.2.5 Sanofi Aventis Recent Developments
  13. 7.3 MCW Healthcare
  14. 7.3.1 MCW Healthcare Company Information
  15. 7.3.2 MCW Healthcare Business Overview
  16. 7.3.3 MCW Healthcare Artesunate Medicines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MCW Healthcare Artesunate Medicines Product Portfolio
  18. 7.3.5 MCW Healthcare Recent Developments
  19. 7.4 Ipca Laboratories
  20. 7.4.1 Ipca Laboratories Company Information
  21. 7.4.2 Ipca Laboratories Business Overview
  22. 7.4.3 Ipca Laboratories Artesunate Medicines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ipca Laboratories Artesunate Medicines Product Portfolio
  24. 7.4.5 Ipca Laboratories Recent Developments
  25. 7.5 Fosun Pharma (Guilin)
  26. 7.5.1 Fosun Pharma (Guilin) Company Information
  27. 7.5.2 Fosun Pharma (Guilin) Business Overview
  28. 7.5.3 Fosun Pharma (Guilin) Artesunate Medicines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio
  30. 7.5.5 Fosun Pharma (Guilin) Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla Artesunate Medicines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cipla Artesunate Medicines Product Portfolio
  36. 7.6.5 Cipla Recent Developments
  37. 7.7 Ajanta Pharma
  38. 7.7.1 Ajanta Pharma Company Information
  39. 7.7.2 Ajanta Pharma Business Overview
  40. 7.7.3 Ajanta Pharma Artesunate Medicines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ajanta Pharma Artesunate Medicines Product Portfolio
  42. 7.7.5 Ajanta Pharma Recent Developments
  43. 7.8 Acino
  44. 7.8.1 Acino Company Information
  45. 7.8.2 Acino Business Overview
  46. 7.8.3 Acino Artesunate Medicines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Acino Artesunate Medicines Product Portfolio
  48. 7.8.5 Acino Recent Developments
8 North America
  1. 8.1 North America Artesunate Medicines Revenue (2021-2032)
  2. 8.2 North America Artesunate Medicines Revenue by Type (2021-2032)
  3. 8.2.1 North America Artesunate Medicines Revenue by Type (2021-2026)
  4. 8.2.2 North America Artesunate Medicines Revenue by Type (2027-2032)
  5. 8.3 North America Artesunate Medicines Revenue Share by Type (2021-2032)
  6. 8.4 North America Artesunate Medicines Revenue by Application (2021-2032)
  7. 8.4.1 North America Artesunate Medicines Revenue by Application (2021-2026)
  8. 8.4.2 North America Artesunate Medicines Revenue by Application (2027-2032)
  9. 8.5 North America Artesunate Medicines Revenue Share by Application (2021-2032)
  10. 8.6 North America Artesunate Medicines Revenue by Country
  11. 8.6.1 North America Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artesunate Medicines Revenue by Country (2021-2026)
  13. 8.6.3 North America Artesunate Medicines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Artesunate Medicines Revenue (2021-2032)
  2. 9.2 Europe Artesunate Medicines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artesunate Medicines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artesunate Medicines Revenue by Type (2027-2032)
  5. 9.3 Europe Artesunate Medicines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artesunate Medicines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artesunate Medicines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artesunate Medicines Revenue by Application (2027-2032)
  9. 9.5 Europe Artesunate Medicines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artesunate Medicines Revenue by Country
  11. 9.6.1 Europe Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artesunate Medicines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artesunate Medicines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Artesunate Medicines Revenue (2021-2032)
  2. 10.2 China Artesunate Medicines Revenue by Type (2021-2032)
  3. 10.2.1 China Artesunate Medicines Revenue by Type (2021-2026)
  4. 10.2.2 China Artesunate Medicines Revenue by Type (2027-2032)
  5. 10.3 China Artesunate Medicines Revenue Share by Type (2021-2032)
  6. 10.4 China Artesunate Medicines Revenue by Application (2021-2032)
  7. 10.4.1 China Artesunate Medicines Revenue by Application (2021-2026)
  8. 10.4.2 China Artesunate Medicines Revenue by Application (2027-2032)
  9. 10.5 China Artesunate Medicines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artesunate Medicines Revenue (2021-2032)
  2. 11.2 Asia Artesunate Medicines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artesunate Medicines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artesunate Medicines Revenue by Type (2027-2032)
  5. 11.3 Asia Artesunate Medicines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artesunate Medicines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artesunate Medicines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artesunate Medicines Revenue by Application (2027-2032)
  9. 11.5 Asia Artesunate Medicines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artesunate Medicines Revenue by Country
  11. 11.6.1 Asia Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artesunate Medicines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artesunate Medicines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artesunate Medicines Revenue (2021-2032)
  2. 12.2 SAMEA Artesunate Medicines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artesunate Medicines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artesunate Medicines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artesunate Medicines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artesunate Medicines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artesunate Medicines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artesunate Medicines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artesunate Medicines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artesunate Medicines Revenue by Country
  11. 12.6.1 SAMEA Artesunate Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artesunate Medicines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artesunate Medicines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst